List of Excipients in API daridorexant
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing daridorexant
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | FERRIC OXIDE RED | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | FERROSOFERRIC OXIDE | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | GLYCERIN | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | HYPROMELLOSE | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | MAGNESIUM STEARATE | 2034-12-02 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for daridorexant
Excipient focus: FERRIC OXIDE RED
daridorexant drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
daridorexant drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
daridorexant drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
daridorexant drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
daridorexant drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
daridorexant drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
daridorexant drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
daridorexant drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
daridorexant drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
daridorexant drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
daridorexant drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
daridorexant drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
daridorexant drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
daridorexant drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
